Prospective Study of HIV Infection in Hemophiliacs (NCT00005309) | Clinical Trial Compass
CompletedNot Applicable
Prospective Study of HIV Infection in Hemophiliacs
Started 1990-07
Plain-language summary
To examine mechanisms of individual differences in the progression of HIV infection in hemophiliacs.
Who can participate
Age range
100 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
No eligibility criteria
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is listed as completed — does that mean the findings have been published, and if so, what did they show about how HIV infection progresses in people with hemophilia?
2Since this study also tracked conditions like hepatitis and cytomegalovirus alongside HIV, would my doctor recommend I get tested or monitored for those co-infections as part of my own care?
3Given that this was a prospective observational study rather than a treatment trial, does the data it collected have any practical impact on the treatment options or monitoring schedules my doctor might recommend for me today?
4Because this study focused specifically on hemophiliacs who contracted HIV, possibly through blood products or transfusions, how does that historical context affect the way my doctor would approach managing both my hemophilia and any HIV-related concerns now?
5Are there any current active studies or updated treatment protocols that have built on what this completed research found, and would it be worth discussing whether any of those might be relevant to my situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.